Spread of CTX-M-type extended-spectrum β-lactamases among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae from a Korean hospital

Diagnostic Microbiology and Infectious Disease

Volumn 63, Issue 1, 2009, Pages 76-80

  Lee, Sang Guk ^a   Jeong, Seok Hoon ^a   Lee, Hyukmin ^a,b   Kim, Chang Ki ^a,c   Lee, Yangsoon ^a   Koh, Eunmi ^a   Chong, Yunsop ^a   Lee, Kyungwon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Korean Institute of Tuberculosis   (South Korea)

Author keywords

CTX M 14; CTX M 15; CTX M 24; CTX M 27; CTX M 32; CTX M 65; Korea

Indexed keywords

BACTERIAL ENZYME; ENZYME VARIANT; EXTENDED SPECTRUM BETA LACTAMASE; PROTEIN CTX M; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SOUTH KOREA;

BACTEREMIA; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; KOREA; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHENOTYPE; PREVALENCE;

EID: 57349089787     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.09.002     Document Type: Article

References (21)

1. Bauernfeind A., Rosenthal E., Eberlein E., Holley M., and Schweighart S. Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients. Infection 21 (1993) 18-22
2. Bonnet R., Recule C., Baraduc R., Chanal C., Sirot D., De Champs C., and Sirot J. Effect of D240G substitution in a novel ESBL CTX-M-27. J. Antimicrob. Chemother. 52 (2003) 29-35
3. Bouallegue-Godet O., Ben Salem Y., Fabre L., Demartin M., Grimont P.A., Mzoughi R., and Weill F.X. Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum β-lactamase in a neonatal unit in Sousse, Tunisia. J. Clin. Microbiol. 43 (2005) 1037-1044
4. Cartelle M., del Mar Tomas M., Molina F., Moure R., Villanueva R., and Bou G. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob. Agents Chemother. 48 (2004) 2308-2313
5. Chanawong A., M'Zali F.H., Heritage J., Xiong J.H., and Hawkey P.M. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob. Agents Chemother. 46 (2002) 630-637
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standard M2-A9. 9th ed. (2006), CLSI, Wayne (PA)
7. CTX-M genes. J. Antimicrob. Chemother. 57 (2006) 14-23
8. CTX-M gene expression. J. Antimicrob. Chemother. 59 (2007) 841-847
9. Hawkey P.M. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin. Microbiol. Infect. 14 Suppl 1 (2008) 159-165
10. Jacoby G.A., and Medeiros A.A. More extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 35 (1991) 1697-1704
11. Knothe H., Shah P., Krcmery V., Antal M., and Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11 (1983) 315-317
12. Ko K.S., Lee M.Y., Song J.H., Lee H., Jung D.S., Jung S.I., Kim S.W., Chang H.H., Yeom J.S., Kim Y.S., Ki H.K., Chung D.R., Kwon K.T., Peck K.R., and Lee N.Y. Prevalence and characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn. Microbiol. Infect. Dis. 61 (2008) 453-459
13. Lewis II J.S., Herrera M., Wickes B., Patterson J.E., and Jorgensen J.H. First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother. 51 (2007) 4015-4021
14. Livermore D.M., Canton R., Gniadkowski M., Nordmann P., Rossolini G.M., Arlet G., Ayala J., Coque T.M., Kern-Zdanowicz I., Luzzaro F., Poirel L., and Woodford N. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59 (2007) 165-174
15. Matsumoto Y., Ikeda F., Kamimura T., Yokota Y., and Mine Y. Novel plasmid-mediated β-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins. Antimicrob. Agents Chemother. 32 (1988) 1243-1246
16. Pai H., Choi E.H., Lee H.J., Hong J.Y., and Jacoby G.A. Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J. Clin. Microbiol. 39 (2001) 3747-3749
17. Pai H., Lyu S., Lee J.H., Kim J., Kwon Y., Kim J.W., and Choe K.W. Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J. Clin. Microbiol. 37 (1999) 1758-1763
18. Pitout J.D., Church D.L., Gregson D.B., Chow B.L., McCracken M., Mulvey M.R., and Laupland K.B. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob. Agents Chemother. 51 (2007) 1281-1286
19. Reynolds R., Potz N., Colman M., Williams A., Livermore D., and MacGowan A. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme. J. Antimicrob. Chemother. 53 (2004) 1018-1032
20. Rossolini G.M., D'Andrea M.M., and Mugnaioli C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin. Microbiol. Infect. 14 Suppl 1 (2008) 33-41
21. Ryoo N.H., Kim E.C., Hong S.G., Park Y.J., Lee K., Bae I.K., Song E.H., and Jeong S.H. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J. Antimicrob. Chemother. 56 (2005) 698-702